Product Information
| Property | Description |
|---|---|
| Product Name | Anti-mouse/human Catenin α1 Recombinant Monoclonal Antibody |
| Antibody ID | XM0051 |
| Target Protein | Catenin alpha-1 (α-Catenin / CTNNA1) |
| UniProt Accession | Human: P35221-1, P35221-2, P35221-3; Mouse: P26231 |
| Molecular Weight | Human isoforms: 59.6–102.6 kDa; Mouse: 100.1 kDa |
| Antibody Type | Recombinant monoclonal antibody |
| Host Species | Mouse |
| Recombinant Format | Full-length mouse IgG1 |
| Isotype | Mouse IgG1 |
| Species Reactivity | Mouse and human |
| Tested Applications | WB |
| Recommended Dilution for WB | 1:500–1:5000 |
| Antigen | Recombinant epitope-Fc fusion protein |
| Epitope Sequence | KREKQDETQTKIKRASQKKH |
| Expression System | HEK293 cells |
| Purification | Protein G affinity chromatography |
| Conjugate | Unconjugated |
| Concentration | 0.1 mg/mL |
| Storage Buffer | 0.1 M Tris, 0.05 M Glycine, 0.07 M NaCl, 2 g/L BSA, 50% glycerol, pH 7 |
| Storage Condition | Store at -20°C. |
| Research Use | For research use only. Not for diagnostic or therapeutic applications. |
Product Background
Catenin alpha-1 (α-Catenin / CTNNA1) is a cytoskeletal-associated adhesion protein involved in cadherin-mediated cell-cell adhesion, actin cytoskeleton organization, epithelial integrity, and signal transduction. α-Catenin links cadherin complexes to the actin cytoskeleton and plays critical roles in tissue architecture, mechanotransduction, cell migration, and tumor suppression.
α-Catenin is widely studied in cell adhesion biology, epithelial biology, cancer progression, developmental biology, and cytoskeletal signaling pathways.
Antibody Development
XM0051 was generated by phage-display selection using a mouse-derived antibody library. Recombinant epitope-Fc fusion protein containing the α-Catenin epitope sequence was used as the selection antigen. Following identification of the initial antibody candidate, structure-guided affinity optimization was performed to improve binding affinity and specificity.
The optimized antibody was reconstructed as a full-length mouse IgG1 recombinant antibody and expressed in HEK293 cells.
Binding and specificity were evaluated by:
- ELISA using recombinant epitope-Fc fusion antigen
- Western blot using recombinant MBP-epitope fusion protein
- Western blot detection of endogenous α-Catenin protein in mouse tissues
Validation Data
ELISA Validation
ELISA demonstrated specific binding to recombinant epitope-Fc fusion antigen, while minimal binding was observed against Fc control protein.
Validation conditions:
- Well 1: Fc control protein
- Well 2: Epitope-Fc fusion protein
- Detection substrate: TMB
Note:
ELISA validation confirms binding to the epitope-Fc fusion antigen. Full-length α-Catenin protein binding in solution has not been tested by ELISA.
Western Blot Validation – Recombinant Fusion Protein
Western blot analysis demonstrated specific recognition of recombinant MBP-epitope fusion protein expressed in BL21(DE3) cells, while no significant binding was observed against MBP control protein.
Validation conditions:
- Lane 1: MBP control protein
- Lane 2: MBP-epitope fusion protein
- Standard reducing Western blot
Western Blot Validation – Endogenous Full-Length Protein
Western blot analysis detected endogenous α-Catenin protein in mouse heart, brain, and lung tissues under reducing conditions.
Validated samples:
- Mouse heart tissue
- Mouse brain tissue
- Mouse lung tissue
Detection condition:
- Standard reducing Western blot
- HRP-conjugated anti-mouse secondary antibody
Observed bands:
- Major bands observed near expected α-Catenin molecular weights
- Additional lower molecular weight bands may represent processed protein species or isoforms















